HSINCHU, TAIWAN – June 17, 2014 – JHL Biotech, Inc., an emerging biopharmaceutical company, today announced that it has closed a Series B financing round of $35 million, led by... read more →
JHL Biotech to develop and commercialize BL-9020 in China and additional Southeast Asia countries Jerusalem, Israel and Hsinchu, Taiwan – January 8, 2014 – BioLineRx (NASDAQ: BLRX; TASE: BLRX), a... read more →
Strategic Alliance to Provide Seamless Services from Cell Line Development to cGMP Manufacturing of Biologic Drugs Hsinchu, Taiwan and Geneva, Switzerland – 3 December 2013 – JHL Biotech, Inc., a... read more →
CHALFONT ST GILES, UK and HSINCHU, TAIWAN – 2 December 2013 –GE Healthcare Life Sciences, (NYSE: GE), and JHL Biotech today announced that GE Healthcare has completed installation of its... read more →
New factory to give JHL Biotech commercial biopharmaceutical manufacturing capabilities in Asia Chalfont St Giles, UK and Wuhan, China – 25 September 2013 – GE Healthcare Life Sciences, a business ... read more →
JHL Biotech participated in this year’s Biotechnology Industry Organization (BIO) Convention in Chicago, as the representative of Biolake. Founded in 1993, the BIO International Convention is held annually and is... read more →
On March 28, 2013, Hubei Provincial Party Secretary Hongzhong Li and Governor Guosheng Wang attended a meeting with JHL Biotech and 16 other Biolake companies to discuss the development of... read more →
On March 18th and 19th, Liangzhi Tang, the mayor of Wuhan met with Brook Byers, one of the four founders of Kleiner Perkins Caufield& Byers (KPCB). The two spoke about... read more →
On March 13, 2013, leaders from JHL Biotech and GE Healthcare Life Sciences signed a strategic cooperation agreement. The two companies will build a monoclonal antibody manufacturing plant in Wuhan’s... read more →